• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经肌肉传递障碍的临床方面

Clinical aspects of neuromuscular transmission disorders.

作者信息

Evoli Amelia

机构信息

Neuroscience Department, Catholic University, Roma, Italy.

出版信息

Acta Neurol Scand Suppl. 2006;183:8-11. doi: 10.1111/j.1600-0404.2006.00606.x.

DOI:10.1111/j.1600-0404.2006.00606.x
PMID:16637919
Abstract

Autoimmune disorders of neuromuscular transmission are caused by antibodies (abs) directed against membrane proteins at the motor end-plate. Myasthenia gravis (MG) is due, in most cases, to abs against the nicotinic acetylcholine receptor (AChR). Anti-AChR-positive MG actually includes different disease entities: weakness can be confined to extrinsic ocular muscles or can be generalized; patients with generalized MG (G-MG) can be subdivided on the basis of age of onset, HLA association and thymic pathology. About 15% of G-MG patients are anti-AChR-negative; in a proportion of these cases serum abs against the muscle- specific kinase (MuSK) are found. Anti-MuSK-positive MG is characterized by predominant involvement of bulbar muscles and very low frequency of thymic pathology. The Lambert-Eaton myasthenic syndrome (LEMS) is caused by abs against voltage-gated calcium channels at nerve terminal. LEMS is characterized by muscle weakness and autonomic disturbances and it is paraneoplastic in over 50% of the cases. In neuromyotonia and cramp-fasciculation syndrome, that are thought to be due to anti-voltage-gated potassium channel abs, signs of peripheral nerve hyperexcitability can be associated with CNS features.

摘要

自身免疫性神经肌肉传递障碍由针对运动终板膜蛋白的抗体引起。重症肌无力(MG)在大多数情况下是由于针对烟碱型乙酰胆碱受体(AChR)的抗体所致。抗AChR阳性的MG实际上包括不同的疾病实体:肌无力可局限于眼外肌或为全身性;全身性MG(G-MG)患者可根据发病年龄、HLA相关性和胸腺病理进行细分。约15%的G-MG患者抗AChR阴性;在这些病例中,一部分患者血清中可检测到针对肌肉特异性激酶(MuSK)的抗体。抗MuSK阳性的MG以延髓肌受累为主且胸腺病理发生率极低为特征。兰伯特-伊顿肌无力综合征(LEMS)由针对神经末梢电压门控钙通道的抗体引起。LEMS的特征是肌无力和自主神经功能紊乱,超过50%的病例为副肿瘤性。在被认为由抗电压门控钾通道抗体引起的神经性肌强直和肌束震颤综合征中,周围神经兴奋性增高的体征可伴有中枢神经系统特征。

相似文献

1
Clinical aspects of neuromuscular transmission disorders.神经肌肉传递障碍的临床方面
Acta Neurol Scand Suppl. 2006;183:8-11. doi: 10.1111/j.1600-0404.2006.00606.x.
2
[Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].[兰伯特-伊顿肌无力综合征中针对突触前P/Q型电压门控钙通道的自身抗体]
Brain Nerve. 2013 Apr;65(4):441-8.
3
Myasthenia gravis Lambert-Eaton overlap syndrome.重症肌无力-兰伯特-伊顿重叠综合征
Muscle Nerve. 2016 Jan;53(1):20-6. doi: 10.1002/mus.24921. Epub 2015 Nov 26.
4
[Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].[神经肌肉传递障碍的免疫学方面。2. 实验性自身免疫性重症肌无力和兰伯特-伊顿肌无力综合征]
Lijec Vjesn. 1994 May-Jun;116(5-6):158-61.
5
[Editorial introduction: from the structure and functions of the neuromuscular junction to the diseases].[编辑引言:从神经肌肉接头的结构与功能到相关疾病]
Brain Nerve. 2011 Jul;63(7):635-40.
6
Myasthenic syndromes.肌无力综合征。
J R Coll Physicians Edinb. 2011 Mar;41(1):43-7; quiz 48. doi: 10.4997/JRCPE.2011.111.
7
Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.重症肌无力和 Lambert-Eaton 肌无力综合征的治疗进展。
Neurol Clin. 2021 Feb;39(1):133-146. doi: 10.1016/j.ncl.2020.09.007. Epub 2020 Nov 7.
8
[Paraneoplastic diseases of the motor end-plate and muscle].
Rev Neurol. 2000;31(12):1225-8.
9
Guidelines for treatment of autoimmune neuromuscular transmission disorders.自身免疫性神经肌肉传递障碍治疗指南。
Eur J Neurol. 2010 Jul;17(7):893-902. doi: 10.1111/j.1468-1331.2010.03019.x. Epub 2010 Apr 12.
10
[The pathophysiology and treatment of autoimmune neuromuscular junction diseases].[自身免疫性神经肌肉接头疾病的病理生理学与治疗]
Rinsho Shinkeigaku. 2011 Nov;51(11):872-6. doi: 10.5692/clinicalneurol.51.872.

引用本文的文献

1
Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment.抗肌肉特异性激酶的重症肌无力:临床特征、病理生理学及治疗的最新进展
Front Mol Neurosci. 2020 Sep 2;13:159. doi: 10.3389/fnmol.2020.00159. eCollection 2020.